Stock listing
TASE:DRTS Alpha Tau Medical Ltd מניה
Israeli listing (TASE) of Alpha Tau Medical Ltd · home listing NASDAQ:DRTS
Follow Alpha Tau Medical Ltd into a list and get an email when it puts out news.
Home listing price · NASDAQ:DRTS
$12.83 USD -0.23 (-1.8%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:DRTS
- Day range
- $12.67 – $13.23 USDNov 2, 2026
- Volume
- 436,732 sharesNov 2, 2026
- Market cap
- $1.19B USDAt the close on Nov 2, 2026 · price × 92.48M shares outstanding
- 52-week range
- $3.43 – $15.79 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $7.46M USDMedian day 447,711 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DRTS · Home | $12.83 USD | -0.23 (-1.8%) | 436,732 | $13.22 | $13.23 | $12.67 | $13.06 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:DRTS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $12.83 | -0.23 | -1.8% | $13.22 | $13.23 | $12.67 | 436,732 | |
| $13.06 | -0.17 | -1.3% | $12.85 | $13.15 | $12.74 | 475,222 | |
| $13.23 | -0.12 | -0.9% | $13.31 | $13.55 | $13.06 | 282,833 | |
| $13.35 | -0.16 | -1.2% | $13.51 | $13.61 | $13.27 | 401,163 | |
| $13.51 | +0.62 | +4.8% | $12.99 | $13.66 | $12.71 | 341,843 | |
| $12.89 | -0.27 | -2.1% | $13.18 | $13.56 | $12.77 | 379,003 | |
| $13.16 | +0.26 | +2.0% | $12.75 | $13.25 | $12.70 | 324,175 | |
| $12.90 | -0.58 | -4.3% | $13.25 | $13.46 | $12.71 | 447,711 | |
| $13.48 | +0.39 | +3.0% | $13.47 | $13.85 | $13.30 | 500,316 | |
| $13.09 | +0.47 | +3.7% | $12.61 | $13.38 | $12.50 | 833,535 | |
| $12.62 | +0.33 | +2.7% | $12.56 | $12.81 | $12.42 | 688,391 | |
| $12.29 | -0.87 | -6.6% | $13.24 | $13.30 | $11.99 | 778,700 | |
| $13.16 | -0.34 | -2.5% | $13.14 | $13.47 | $13.02 | 620,300 | |
| $13.50 | -0.24 | -1.7% | $13.48 | $13.79 | $13.34 | 422,000 | |
| $13.74 | -0.52 | -3.6% | $14.11 | $14.25 | $13.65 | 484,600 | |
| $14.26 | -0.15 | -1.0% | $14.42 | $14.44 | $14.11 | 281,500 | |
| $14.41 | +0.41 | +2.9% | $14.00 | $14.50 | $13.98 | 368,000 | |
| $14.00 | -0.25 | -1.8% | $14.17 | $14.30 | $13.56 | 595,200 | |
| $14.25 | -0.23 | -1.6% | $14.27 | $14.44 | $14.10 | 466,300 | |
| $14.48 | -0.41 | -2.8% | $14.98 | $15.02 | $14.40 | 427,400 | |
| $14.89 | +0.12 | +0.8% | $14.85 | $15.04 | $14.68 | 342,400 | |
| $14.77 | +0.26 | +1.8% | $14.73 | $14.91 | $14.64 | 307,100 | |
| $14.51 | -0.40 | -2.7% | $14.74 | $14.97 | $14.32 | 379,900 | |
| $14.91 | -0.28 | -1.8% | $15.14 | $15.34 | $14.88 | 368,900 | |
| $15.19 | +0.15 | +1.0% | $15.00 | $15.30 | $14.77 | 513,900 | |
| $15.04 | +0.50 | +3.4% | $14.54 | $15.20 | $14.39 | 397,400 | |
| $14.54 | -0.23 | -1.6% | $14.90 | $14.92 | $14.39 | 435,400 | |
| $14.77 | +0.25 | +1.7% | $14.50 | $14.80 | $14.31 | 467,000 | |
| $14.52 | -0.62 | -4.1% | $15.09 | $15.25 | $14.31 | 727,000 | |
| $15.14 | -0.36 | -2.3% | $15.38 | $15.45 | $15.05 | 360,400 | |
| $15.50 | +0.26 | +1.7% | $15.48 | $15.59 | $15.10 | 411,400 | |
| $15.24 | -0.25 | -1.6% | $15.60 | $15.63 | $15.10 | 624,200 | |
| $15.49 | +0.45 | +3.0% | $15.15 | $15.79 | $15.01 | 858,700 | |
| $15.04 | +0.17 | +1.1% | $14.88 | $15.20 | $14.73 | 671,000 | |
| $14.87 | +0.47 | +3.3% | $14.30 | $15.00 | $14.20 | 411,600 | |
| $14.40 | -0.03 | -0.2% | $14.11 | $14.84 | $14.11 | 388,000 | |
| $14.43 | -0.01 | -0.1% | $14.49 | $14.62 | $14.01 | 410,400 | |
| $14.44 | +0.17 | +1.2% | $14.04 | $14.81 | $13.80 | 457,200 | |
| $14.27 | -0.57 | -3.8% | $14.70 | $14.84 | $14.27 | 412,000 | |
| $14.84 | -0.19 | -1.3% | $15.03 | $15.08 | $14.47 | 561,500 | |
| $15.03 | +0.41 | +2.8% | $14.69 | $15.17 | $14.43 | 749,300 | |
| $14.62 | +0.29 | +2.0% | $15.00 | $15.07 | $14.32 | 629,700 | |
| $14.33 | +0.37 | +2.7% | $14.25 | $14.65 | $13.88 | 372,500 | |
| $13.96 | -0.15 | -1.1% | $13.96 | $14.40 | $13.65 | 464,800 | |
| $14.11 | -0.53 | -3.6% | $14.69 | $15.00 | $14.05 | 3,115,700 | |
| $14.64 | -0.17 | -1.1% | $14.76 | $14.90 | $14.45 | 475,300 | |
| $14.81 | -0.15 | -1.0% | $14.83 | $15.10 | $14.75 | 474,500 | |
| $14.96 | +0.26 | +1.8% | $14.70 | $15.00 | $14.58 | 432,500 | |
| $14.70 | 0.00 | 0.0% | $14.74 | $14.98 | $14.50 | 495,000 | |
| $14.70 | -0.22 | -1.5% | $14.93 | $15.00 | $14.57 | 483,400 | |
| $14.92 | +0.56 | +3.9% | $14.57 | $15.02 | $14.40 | 626,200 | |
| $14.36 | -0.11 | -0.8% | $14.47 | $14.60 | $14.20 | 349,200 | |
| $14.47 | +0.21 | +1.5% | $14.52 | $14.70 | $14.17 | 652,000 | |
| $14.26 | +0.11 | +0.8% | $14.00 | $14.57 | $13.77 | 374,800 | |
| $14.15 | -0.10 | -0.7% | $14.40 | $14.55 | $13.87 | 445,300 | |
| $14.25 | -0.25 | -1.7% | $14.41 | $14.52 | $14.14 | 314,400 | |
| $14.50 | +0.63 | +4.5% | $14.37 | $14.75 | $14.05 | 886,300 | |
| $13.87 | -0.40 | -2.8% | $14.38 | $14.40 | $13.41 | 500,600 | |
| $14.27 | +0.67 | +4.9% | $13.43 | $14.30 | $13.31 | 883,000 | |
| $13.60 | +0.46 | +3.5% | $13.15 | $13.74 | $13.11 | 594,700 | |
| $13.14 | +0.15 | +1.2% | $13.25 | $13.50 | $13.10 | 297,000 | |
| $12.99 | -0.27 | -2.0% | $13.31 | $13.55 | $12.80 | 379,200 | |
| $13.26 | +0.18 | +1.4% | $12.90 | $13.49 | $12.89 | 344,000 | |
| $13.08 | +1.16 | +9.7% | $12.10 | $13.13 | $12.10 | 582,800 | |
| $11.92 | +0.13 | +1.1% | $11.69 | $11.94 | $11.40 | 330,500 |
- Ticker
- TASE:DRTS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TASE
- Currency
- ILA
What changed lately
Latest news release · Oct 22, 2026
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
Latest deck · Aug 22, 2026
Investor Presentation (August 2026)
Investor deck · 41 slides
Latest news
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
Oct 22, 2026
Closed $12.90 (-4.3%) on Oct 22, 2026
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
Oct 19, 2026
Closed $12.62 (+2.7%) on Oct 19, 2026
Alpha Tau to Participate in October Investor Conferences
Oct 5, 2026
Closed $14.89 (+0.8%) on Oct 5, 2026
Alpha Tau to Participate in September Investor Conferences
Sep 2, 2026
Closed $14.33 (+2.7%) on Sep 2, 2026
Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions
Aug 31, 2026
Closed $14.11 (-3.6%) on Aug 31, 2026
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 10, 2026
Closed $14.27 (+4.9%) on Aug 11, 2026
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold for Success
Jul 21, 2026
Closed $13.32 (-1.1%) on Jul 21, 2026
Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
Jul 15, 2026
Closed $12.46 (+1.0%) on Jul 15, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 41 slides · Aug 22, 2026
Technical Presentation (May 2026)
Technical · 52 slides · May 2026
Investor Presentation (March 2026)
Investor deck · 37 slides · Mar 9, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 34 slides · Jan 5, 2026
Alpha Tau Medical Ltd on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 47 in all · newest Oct 22, 2026 · oldest 2025
- Decks
- 8 decks · latest Aug 22, 2026
Where Alpha Tau Medical Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DRTS · Home listing | NASDAQ | United States | USD |
| TASE:DRTS · This page | TASE | Israel | ILA |
| BOATS:DRTS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Alpha Tau Medical Ltd.